Literature DB >> 21532234

Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder.

Ken Ikeda1, Hirono Ito, Takanobu Hidaka, Takanori Takazawa, Tokinori Sekine, Yasuhiro Yoshii, Takehisa Hirayama, Kiyokazu Kawabe, Osamu Kano, Yasuo Iwasaki.   

Abstract

A 51-year-old woman had developed fever and consciousness disturbance at 47 years of age. Brain magnetic resonance imaging (MRI) revealed acute disseminating encephalomyelitis (ADEM)-like lesions without gadolinium enhancement (GDE). One year later, she had an episode of bilateral optic neuritis and cerebellar ataxia. Speech deficit and right hand weakness occurred at the age of 51 years. Neurological examination showed motor aphasia, finger agnosia, right-left disorientation, and right hand paresis. Neuromyelitis optica (NMO)-IgG was seropositive. Cerebrospinal fluid examination showed negative results for myelin basic protein and oligoclonal IgG band. The IgG index was normal. Brain MRI revealed a tumefactive lesion in the left temporo-parietal region and conglomerate ovoid lesions in the pericallosal regions. No GDE was found in the brain lesions. Visual evoked potential test showed bilateral prolongation of P100 latencies. She was treated twice with methylprednisolone pulse therapy followed by oral prednisolone, but the motor aphasia did not respond to steroid treatment. She had no prior history of myelitis and was diagnosed as NMO spectrum disorder (NMOSD). Similar to previous studies of NMO-IgG seropositive extensive brain lesions, this patient with NMOSD indicated no GDE in tumefactive lesions at two episodes of encephalopathy. Compared to multiple sclerosis (MS), a high frequency of non-enhancing tumefactive lesions is reported in patients with NMO or NMOSD. The absence of GDE in tumefactive lesions could help to differentiate between NMO and MS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21532234     DOI: 10.2169/internalmedicine.50.4295

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Brain MRI in neuromyelitis optica: what is its role?

Authors:  Wei Qiu; Allan G Kermode
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

3.  Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy.

Authors:  Mkael Symmonds; Niranjanan Nirmalananthan; Graham P Taylor; Leslie R Bridges; Frederick Schon
Journal:  J Neurol       Date:  2012-08-24       Impact factor: 4.849

Review 4.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

Review 5.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

6.  Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.

Authors:  Jens Harmel; Marius Ringelstein; Jens Ingwersen; Christian Mathys; Norbert Goebels; Hans-Peter Hartung; Sven Jarius; Orhan Aktas
Journal:  BMC Neurol       Date:  2014-12-17       Impact factor: 2.474

7.  Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.

Authors:  Masataka Nakamura; Kumi Itani; Kousuke Miyake; Takenobu Kunieda; Satoshi Kaneko; Hirofumi Kusaka
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

8.  Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity.

Authors:  Youming Long; Junyan Liang; Linzhan Wu; Shaopeng Lin; Cong Gao; Xiaohui Chen; Wei Qiu; Yu Yang; Xueping Zheng; Ning Yang; Min Gao; Yaotang Chen; Zhanhang Wang; Quanxi Su
Journal:  Front Neurol       Date:  2017-02-28       Impact factor: 4.003

Review 9.  Molecular pathogenesis of neuromyelitis optica.

Authors:  Wajih Bukhari; Michael H Barnett; Kerri Prain; Simon A Broadley
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

10.  Clinical Profiles and Short-Term Outcomes of Acute Disseminated Encephalomyelitis in Adult Chinese Patients.

Authors:  Hong Qi Yang; Wen Cong Zhao; Wei Min Yang; Yong Li Li; Zhi Kun Sun; Shuai Chen; Wei Li; Jian Jun Ma
Journal:  J Clin Neurol       Date:  2016-07       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.